NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer

Chio, Iok In Christine, Jafarnejad, Seyed Mehdi, Ponz-Sarvise, Mariano, Park, Youngkyu, Rivera, Keith, Palm, Wilhelm, Wilson, John, Sangar, Vineet +18 more·2016·Cell

DOI 10.1016/j.cell.2016.06.056

Cited by (378)

Items 101–200 of 378

The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting
Nicolas Jonckheere, Romain Vasseur, Isabelle VAN SEUNINGEN · 2017 · Critical Reviews in Oncology/Hematology
Contribution of NRF2 to sulfur metabolism and mitochondrial activity
Md. Morshedul Alam, Akihiro Kishino, Eunkyu Sung, Hiroki Sekine, Takaaki Abe, Shohei Murakami, Takaaki Akaike, Hozumi Motohashi · 2023 · Redox Biology
The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology
Juha M. T. Hyttinen, Ram Kannan, Szabolcs Felszeghy, Minna Niittykoski, Antero Salminen, Kai Kaarniranta · 2019 · International Journal of Molecular Sciences
Antioxidant Activity during Tumor Progression: A Necessity for the Survival of Cancer Cells?
Mark A. Hawk, Chelsea Marie McCallister, Zachary T. Schafer · 2016 · Cancers
Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Valeria Merz, Marina Gaule, Camilla Zecchetto, Alessandro Cavaliere, Simona Casalino, Camilla Pesoni, Serena Contarelli, Fabio Sabbadini, Monica Bertolini, Domenico Mangiameli et al. · 2021 · Frontiers in Oncology
Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells
Petra Jagušt, Sonia Alcalá, Bruno Sáinz, Christopher Heeschen, Patricia Sancho · 2020 · World Journal of Stem Cells
NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis
Haoyan Guo, Jiaqian Xu, Quan Zheng, Jianli He, Wei Zhou, Kezhou Wang, Xian Huang, Qiuju Fan, Jiao Ma, Jinke Cheng et al. · 2019 · Cancer Letters
Cellular Responses to Proteasome Inhibition: Molecular Mechanisms and Beyond
Nicolás Albornoz, Hianara Aracelly Bustamante, Andrea Soza, Patricia V. Burgos · 2019 · International Journal of Molecular Sciences
The Pleiotropic Role of the KEAP1/NRF2 Pathway in Cancer
Warren Wu, Thales Y. Papagiannakopoulos · 2020 · Annual Review of Cancer Biology
Organoid Models for Cancer Research
Hans C. Clevers, David A. Tuveson · 2019 · Annual Review of Cancer Biology
Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications
Nancy Vargas-Mendoza, Ángel Morales‐González, Mauricio Morales-Martínez, Marvin Antonio Soriano-Ursua, Luis Delgado‐Olivares, Eli Mireya Sandoval-Gallegos, Eduardo Madrigal‐Bujaidar, Isela Álvarez‐González, Eduardo Madrigal‐Santillán, José A. Morales‐González · 2020 · Biomedicines
Targeting Redox Metabolism in Pancreatic Cancer
Nadine Abdel Hadi, Gabriela Reyes‐Castellanos, Alice Carrier · 2021 · International Journal of Molecular Sciences
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function
Manojit Mosur Swamynathan, Shan Kuang, Kaitlin E. Watrud, Mary R. Doherty, Charlotte Gineste, Grinu Mathew, Grace Qun Gong, Hilary Cox, Eileen Cheng, David J. Reiss et al. · 2024 · Science
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan P. Evans, Boleslaw K. Winiarski, Paul Anthony Sutton, Robert Peter Jones, Lorenzo Ressel, Carrie A. Duckworth, David Mark Pritchard, Zhi‐Xiu Lin, Vicky L. Fretwell, Elizabeth M. Tweedle et al. · 2018 · Oncotarget
Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis
Qiqing Sun, Ye Zeng, Yi Qin, Guixiong Fan, Shunrong Ji, Qifeng Zhuo, Wenyan Xu, Wensheng Liu, Qiangsheng Hu, Mengqi Liu et al. · 2020 · Oncogene
The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance
Kalyani Patil, Khan Farheen Badrealam, Sabah Akhtar, Aamir Ahmad, Shahab Uddin M.S. · 2021 · Cancer and Metastasis Reviews
A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer
Tiantian Xu, Qisheng Ma, Yanan Li, Qing Yu, Peichen Pan, Yawen Zheng, Zhijian Li, Xiufang Xiong, Tingjun Hou, Bin Yu et al. · 2022 · Signal Transduction and Targeted Therapy
Nrf2 promotes mutant K-ras/p53-driven pancreatic carcinogenesis
Shin Hamada, Keiko Taguchi, Atsushi Masamune, Masayuki P. Yamamoto, Tooru Shimosegawa · 2017 · Carcinogenesis
Initiation, Expansion, and Cryopreservation of Human Primary Tissue‐Derived Normal and Diseased Organoids in Embedded Three‐Dimensional Culture
James Clinton, Penney McWilliams‐Koeppen · 2018 · Current Protocols in Cell Biology
Neuroprotective Effect of Salvianolic Acid A against Diabetic Peripheral Neuropathy through Modulation of Nrf2
Chunyang Xu, Biyu Hou, Ping He, Peng Ma, Xinyu Yang, Xiuying Yang, Li Zhang, Guifen Qiang, Wenlan Li, Guanhua Du · 2020 · Oxidative Medicine and Cellular Longevity
Brusatol: A potential sensitizing agent for cancer therapy from Brucea javanica
Ting He, Fangli Zhou, Anping Su, Yujie Zhang, Zhichao Xing, Li Mi, Zhihui Li, Wenshuang Wu · 2022 · Biomedicine & Pharmacotherapy
A distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutations
Daniel C. Levings, Xuting Wang, Derek Kohlhase, Douglas A. Bell, Matthew G. Slattery · 2018 · Redox Biology
FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide
Li Zhang, Handong Wang · 2017 · Pharmacological Reports
Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
Daniela Carlisi, Marianna Lauricella, Antonella D’Anneo, Anna DE BLASIO, Adriana Celesia, Giovanni Pratelli, Antonietta Notaro, Giuseppe Calvaruso, Michela Giuliano, Sonia Emanuele · 2022 · Biomedicines
Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase
Jin Hyang Song, Neha Singh, Libia A. Luevano, Sathish K.R. Padi, Koichi Okumura, Virginie Olive, Stephen M. Black, Noel A. Warfel, David W. Goodrich, Andrew S. Kraft · 2018 · Molecular Cancer Therapeutics
Fatty-acid receptor CD36 functions as a hydrogen sulfide-targeted receptor with its Cys333-Cys272 disulfide bond serving as a specific molecular switch to accelerate gastric cancer metastasis
Rui Wang, Bei‐Bei Tao, Qilin Fan, Shengyue Wang, Li Chen, Junjie Zhang, Yinfang Hao, Shuang Dong, Zhe Wang, Wei Wang et al. · 2019 · EBioMedicine
REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors
Shuxi Qiao, Siang‐Boon Koh, Varunika Vivekanandan, Devika Salunke, Krushna Chandra Patra, Elma Zaganjor, Kenneth N. Ross, Yusuke Mizukami, Sarah Jeanfavre, Athena L. Chen et al. · 2020 · Genes & Development
Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress
Aushia Tanzih Al Haq, Hong‐Yu Tseng, Li‐Mei Chen, Chien‐Chia Wang, Hsin-Ling Hsu · 2022 · Cell Death and Disease
Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation
Xueyan Zhou, Yun Zhao, Juan Wang, Xi Wang, Chunxia Chen, Di Yin, Feng Zhao, Jiale Yin, Meng Guo, Longzhen Zhang et al. · 2018 · Biochemical Pharmacology
Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase-1 inhibition
Maher Y. Abdalla, Iman M. Ahmad, Satyanarayana Rachagani, Kasturi Banerjee, Christopher M. Thompson, H. Carlo Maurer, Kenneth P. Olive, Katie L. Bailey, Bradley E. Britigan, Sushil Kumar · 2019 · Translational research
Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
Emiliano Panieri, Luciano Saso · 2021 · Antioxidants and Redox Signaling
Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study
Senling Feng, Hai‐Bin Luo, Liang Cai, Jie Zhang, Dan Wang, Ying-Jiang Chen, Huan-Xing Zhan, Zhi‐Hong Jiang, Ying Xie · 2018 · Journal of Ginseng Research
Systems Biology Approaches to Redox Metabolism in Stress and Disease States
Rui‐Sheng Wang, William M. Oldham, Bradley A. Maron, Joseph Loscalzo · 2017 · Antioxidants and Redox Signaling
ROS mediated EGFR/MEK/ERK/HIF-1α Loop Regulates Glucose metabolism in pancreatic cancer
Gang Wang, Yifeng Li, Zeyu Yang, Weina Xu, Yifan Yang, Xiaodong Tan · 2018 · Biochemical and Biophysical Research Communications
GRP 78‐mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells
Patricia Dauer, Nikita Sharma, Vineet Kumar Gupta, Alice Nomura, Vikas Dudeja, Ashok Kumar Saluja, Sulagna Banerjee · 2018 · Molecular Oncology
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
Gadi Lalazar, David Requena, Lavoisier S. Ramos-Espiritu, Denise Ng, Patrick D. Bhola, Ype P. de Jong, Ruisi Wang, Nicole J.C. Narayan, Bassem Shebl, Solomon Levin et al. · 2021 · Cancer Discovery
A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy
Di Zhang, Zhilin Hou, Kelly E. Aldrich, Lizbeth R. Lockwood, Aaron L. Odom, Karen T. Liby · 2021 · Molecular Cancer Therapeutics
ENO1 silencing impaires hypoxia-induced gemcitabine chemoresistance associated with redox modulation in pancreatic cancer cells.
Lei Wang, Rongrong Bi, Hang Yin, Hailin Liu, Lei Li · 2019 · PubMed Central
Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
Mudasir A. Kumar, Sana Khurshid Baba, Inamu Rashid Khan, Mohd Shahnawaz Khan, Fohad Mabood Husain, Saheem Ahmad, Mohammad Haris, Mayank Singh, Ammira Al‐Shabeeb Akil, Muzafar Ahmad Macha et al. · 2025 · MedComm
Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis
Peter J. Dempsey · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
Jonathan B. Bell, Frank Eckerdt, Harshil Dhruv, Darren Finlay, Sen Peng, Seungchan Kim, Barbara Kroczyńska, Elspeth M. Beauchamp, Kristen Alley, Jessica R. Clymer et al. · 2017 · Molecular Cancer Research
eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer
David Müller, Sauyeun Shin, Théo Goullet de Rugy, Rémi Samain, Romain Baer, Manon Strehaïano, Laìa Masvidal, Julie Guillermet‐Guibert, Christine Jean, Yoshinori Tsukumo et al. · 2019 · JCI Insight
Reductive stress in striated muscle cells
Ilaria Bellezza, Francesca Riuzzi, Sara Chiappalupi, Cataldo Arcuri, Ileana Giambanco, Guglielmo Sorci, Rosario Donato · 2020 · Cellular and Molecular Life Sciences
NRF2‐dependent stress defense in tumor antioxidant control and immune evasion
José Pedro Friedmann Angeli, Svenja Meierjohann · 2020 · Pigment Cell & Melanoma Research
Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
Singh, Kamini, Lin, Jianan, Lecomte, Nicolas, Mohan, Prathibha, Gokce, Askan, Sanghvi, Viraj R., Jiang, Man, Grbovic-Huezo, Olivera, Burčul, Antonija, Stark, Stefan G. et al. · 2021 · Cancer Research
Proteome Stability as a Key Factor of Genome Integrity
Sentiljana Gumeni, Zoi Evangelakou, Vassilis G. Gorgoulis, Ioannis P. Trougakos · 2017 · International Journal of Molecular Sciences
The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen
Xiaoqing Zheng, Yifan Chen, Man Bai, Yuxi Liu, Binyuan Xu, Ruoxuan Sun, Huihui Zeng · 2018 · Free Radical Biology and Medicine
Oligo-Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression
Li‐Mei Chen, Hong‐Yu Tseng, Yen‐An Chen, Aushia Tanzih Al Haq, Pai‐An Hwang, Hsin-Ling Hsu · 2020 · Cancers
NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant Pancreatic Cancer Cells by Suppressing HO-1 and ABCG2 Expression
Eui Joo Kim, Yoon Jae Kim, Hye In Lee, Seok Hoo Jeong, Hyo Jung Nam, Jae Hee Cho · 2020 · International Journal of Molecular Sciences
Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells
Luping Gao, Yuji Morine, Shinichiro Yamada, Yu Saito, Tetsuya Ikemoto, Kazunori Tokuda, Chie Takasu, Katsuki Miyazaki, Mitsuo Shimada · 2021 · PLoS ONE
A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer
Corina E. Antal, Tae Gyu Oh, Stefan Aigner, En‐Ching Luo, Brian A. Yee, Tania Campos, Hervé Tiriac, Katherine L. Rothamel, Cheng Zhang, Henry Jiao et al. · 2023 · Nature Communications
IKKα inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways
Na‐Young Song, Feng Zhu, Zining Wang, Jami Willette‐Brown, Sichuan Xi, Zhonghe Sun, Ling Su, Xiaolin Wu, Buyong Ma, Ruth Nussinov et al. · 2018 · Proceedings of the National Academy of Sciences
ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer
Vinee Purohit, Lidong Wang, Huibin Yang, Jiufeng Li, Gina M. Ney, Erica R. Gumkowski, Akash J. Vaidya, Annie Wang, Amit Bhardwaj, Ende Zhao et al. · 2021 · Genes & Development
Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
Hiroyoshi Y. Tanaka, Takuya Nakazawa, Atsushi Enomoto, Atsushi Masamune, Mitsunobu R. Kano · 2023 · Cancers
Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype
Steffanus Pranoto Hallis, Jin Myung Kim, Mi‐Kyoung Kwak · 2023 · Molecules and Cells
Genetically Engineered Mouse Models of K-Ras-Driven Lung and Pancreatic Tumors: Validation of Therapeutic Targets
Matthias Drosten, Carmen E. Guerra, Mariano Barbacid · 2017 · Cold Spring Harbor Perspectives in Medicine
The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer
Hadi Fakheri, Mir Amirhossein Sajadi, Ahmad Afrashteh, Wenbiao Ma, Lei Xia, Mohammad Valilo · 2023 · Biochemia Medica
Antioxidants as a Double-Edged Sword in the Treatment of Cancer
Majid Asadi-Samani, Najmeh Kaffash Farkhad, Mohammad‐Reza Mahmoudian‐Sani, Hedayatollah Shirzad · 2019 · IntechOpen eBooks
Zinc antagonizes common carp (Cyprinus carpio) intestinal arsenic poisoning through PI3K/AKT/mTOR signaling cascade and MAPK pathway
Menghao Guo, Yu Wang, Hongjing Zhao, Dongxu Wang, Kai Yin, Yachen Liu, Baoying Li, Mingwei Xing · 2021 · Aquatic Toxicology
Overview of Ferroptosis and Synthetic Lethality Strategies
Yuko Kinowaki, Towako Taguchi, Iichiroh Onishi, Susumu Kirimura, Masanobu Kitagawa, Kouhei Yamamoto · 2021 · International Journal of Molecular Sciences
Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer
Lingyu Han, Weixing Dai, Wenqin Luo, Ye Li, Hongsheng Fang, Shaobo Mo, Qingguo Li, Ye Xu, Renjie Wang, Guoxiang Cai · 2023 · Cancers
Co-targeting autophagy and NRF2 signaling triggers mitochondrial superoxide to sensitize oral cancer stem cells for cisplatin-induced apoptosis
Prakash Priyadarshi Praharaj, Amruta Singh, Srimanta Patra, Sujit K. Bhutia · 2023 · Free Radical Biology and Medicine
Metabolism remodeling in pancreatic ductal adenocarcinoma
Jintao Li, Yi-Ping Wang, Miao Yin, Qun‐Ying Lei · 2019 · Cell Stress
A comprehensive review on signaling attributes of serine and serine metabolism in health and disease
Di Wu, Kejia Zhang, Faheem Ahmed Khan, Nuruliarizki Shinta Pandupuspitasari, Kaifeng Guan, Fei Sun, Chunjie Huang · 2024 · International Journal of Biological Macromolecules
The Role of Nrf2 in the Regulation of Mitochondrial Function and Ferroptosis in Pancreatic Cancer
Dinara M. Baiskhanova, H. Schäfer · 2024 · Antioxidants
Anti-oxidative effects of 4-hydroxybenzyl alcohol in astrocytes confer protective effects in autocrine and paracrine manners
Lidan Luo, Seung-Woo Kim, Hye‐Kyung Lee, Il‐Doo Kim, Hahnbie Lee, Ja-Kyeong Lee · 2017 · PLoS ONE
Generation and Culture of Human Pancreatic Ductal Adenocarcinoma Organoids from Resected Tumor Specimens
Lindsey A. Baker, Hervé Tiriac, David Arthur Tuveson · 2018 · Methods in molecular biology
NRF2 Enables EGFR Signaling in Melanoma Cells
Julia Katharina Charlotte Kreß, Christina Jessen, André Marquardt, Anita Hufnagel, Svenja Meierjohann · 2021 · International Journal of Molecular Sciences
Role of Nrf2 in Pancreatic Cancer
Marta Cykowiak, Violetta Krajka‐Kuźniak · 2021 · Antioxidants
Critical role of KRAS mutation in pancreatic ductal adenocarcinoma
Zhiyao Fan, Kun Fan, Chao Yan, Qiuyi Huang, Yitao Gong, He Cheng, Kaizhou Jin, Chen Liu, Quanxing Ni, Xianjun Yu et al. · 2018 · Translational Cancer Research
Small Molecular Nrf2 Inhibitors as Chemosensitizers for Cancer Therapy
Hongzhi Lin, Yuting Qiao, Hongyu Yang, Qin Nan, Wei Qu, Feng Feng, Wenyuan Liu, Yao Chen, Haopeng Sun · 2020 · Future Medicinal Chemistry
Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer
Mo Shen, Rongbin Qi, Justin Ren, Dongqing Lv, Haihua Yang · 2022 · Frontiers in Oncology
Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake
Yang Liu, Chang Liu, Yu Pan, Jinxin Zhou, Huijun Ju, Yifan Zhang · 2022 · Cell Death Discovery
NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy
Sanghvi, Viraj R., Mohan, Prathibha, Singh, Kamini, Cao, Linlin, Berishaj, Marjan, Wolfe, Andrew L., Schatz, Jonathan H., Lailler, Nathalie, de Stanchina, Elisa, Viale, Agnes et al. · 2021 · Cancers
Cullin 3 and Its Role in Tumorigenesis
Ruey‐Hwa Chen · 2020 · Advances in experimental medicine and biology
Molecular Therapeutics of Pancreatic Ductal Adenocarcinoma: Targeted Pathways and the Role of Cancer Stem Cells
Andrei-Florian Stoica, Chao‐Hui Chang, Siim Pauklin · 2020 · Trends in Pharmacological Sciences
Mass Spectrometry Reveals High Levels of Hydrogen Peroxide in Pancreatic Cancer Cells
Qinlei Liu, Wenjie Ge, Sandra Martínez‐Jarquín, Yuliang He, Ri Wu, Markus Stoffel, Renato Zenobi · 2023 · Angewandte Chemie International Edition
Organic Selenium induces ferroptosis in pancreatic cancer cells
Roberta Noè, N. Inglese, Patrizia Romani, Thauan Serafini, C. Paoli, Beatrice Calciolari, Marco Fantuz, Agata Zamborlin, N. C. Surdo, Vittoria Spada et al. · 2023 · Redox Biology
Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway
Jing Li, Jianchao Zhang, Yan Zhu, Lukman Olalekan Afolabi, Liang Chen, Xuesong Feng · 2023 · International Journal of Molecular Sciences
Critical Contribution of Nuclear Factor Erythroid 2-related Factor 2 (NRF2) to Electrophile-induced Interleukin-11 Production
Takashi Nishina, Yutaka Deguchi, R. Miura, Soh Yamazaki, Yasuhiro Shinkai, Yuko Kojima, Ko Okumura, Yoshito Kumagai, Hiroyasu Nakano · 2016 · Journal of Biological Chemistry
A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine
Binhao Chen, Weifeng Jin · 2023 · Frontiers in Neuroscience
Superoxide Dismutases in Pancreatic Cancer
Justin G. Wilkes, Matthew S. Alexander, Joseph J. Cullen · 2017 · Antioxidants
Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges
Ling Gan, Wei Wang, Jinxiu Jiang, Ke Tian, Wei Liu, Zhumin Cao · 2024 · Frontiers in Immunology
Naturally-derived modulators of the Nrf2 pathway and their roles in the intervention of diseases
Tian Wang, Mingjie Liu, Xinyu Li, Sen Zhang, Haoran Gu, Xuan Wei, Xiaoning Wang, Zhen‐Peng Xu, Tao Shen · 2024 · Free Radical Biology and Medicine
Subverted regulation of Nox1 NADPH oxidase-dependent oxidant generation by protein disulfide isomerase A1 in colon carcinoma cells with overactivated KRas
Tiphany Coralie De Bessa, Alessandra Pagano, Ana Iochabel Soares Moretti, Percíllia Oliveira, Samir Andrade Mendonça, Hervé Kovacic, Francisco Rafael Martins Laurindo · 2019 · Cell Death and Disease
ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer
Steffan Vartanian, James Lee, Christiaan N. Klijn, Florian Gnad, Maria Bagniewska, Gabriele Schaefer, Donglu Zhang, Jenille Tan, Sara A. Watson, Liling Liu et al. · 2019 · Cancer Research
Nrf2 Down-Regulation by Camptothecin Favors Inhibiting Invasion, Metastasis and Angiogenesis in Hepatocellular Carcinoma
Qian Liu, Shanshan Zhao, Fanguang Meng, Hankang Wang, Liwei Sun, Guijie Li, Feng Gao, Feng Chen · 2021 · Frontiers in Oncology
MNX1-HNF1B Axis Is Indispensable for Intraductal Papillary Mucinous Neoplasm Lineages
Hiroyuki Kato, Keisuke Tateishi, Hiroaki Fujiwara, Takuma Nakatsuka, Keisuke Yamamoto, Yotaro Kudo, Yoku Hayakawa, Hayato Nakagawa, Yasuo Tanaka, Hideaki Ijichi et al. · 2021 · Gastroenterology
Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation
Hsiu-Yu Liu, Andrea Z. Tuckett, Myles Fennell, Ralph J. Garippa, Johannes L. Zakrzewski · 2018 · Investigational New Drugs
NRF2 negatively regulates primary ciliogenesis and hedgehog signaling
Pengfei Liu, Matthew B. Dodson, Deyu Fang, Eli Chapman, Donna D. Zhang · 2020 · PLoS Biology
Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma
Shin Hamada, Tooru Shimosegawa, Keiko Taguchi, Tatsuhide Nabeshima, Masayuki P. Yamamoto, Atsushi Masamune · 2017 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo
Ryan S. Wible, Quynh T. Tran, Samreen Fathima, Thomas R. Sutter, Thomas W. Kensler, Thomas R. Sutter · 2018 · Molecular Pharmacology
Nrf2 mediates the resistance of human A549 and HepG2 cancer cells to boningmycin, a new antitumor antibiotic, in vitro through regulation of glutathione levels
Huixian Zhang, Yang Chen, Rong Xu, Qiyang He · 2018 · Acta Pharmacologica Sinica
The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment
Ying Li, Ju Zhang, Jie Xu, Shanglong Liu · 2021 · Frontiers in Oncology
HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
Shin Hamada, Ryotaro Matsumoto, Atsushi Masamune · 2022 · Cancers
Transcription Factor NRF2 Participates in Cell Cycle Progression at the Level of G1/S and Mitotic Checkpoints
Diego Lastra, Maribel Escoll, Antonio Cuadrado · 2022 · Antioxidants
Advances in the Genetics and Biology of Pancreatic Cancer
Andrew J. Aguirre, Eric Andrew Collisson · 2017 · The Cancer Journal
Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma
Forum B Kayastha, Noah B. Herrington, Bandish B. Kapadia, Anirban Roychowdhury, Nahid M. Nanaji, Glen E. Kellogg, Ronald B. Gartenhaus · 2022 · Molecular Medicine
Mitochondrial fragmentation in liver cancer: Emerging player and promising therapeutic opportunities
Qian Wang, Pengfei Yu, Chaoxu Liu, Xianli He, Gang Wang · 2022 · Cancer Letters
In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer
Sébastien Martinez, Shifei Wu, Michael J. Geuenich, Ahmad Malik, Ramona Weber, Tristan Woo, Amy Xin Wei Zhang, Gun Ho Jang, Dzana Dervovic, Khalid N. Al‐Zahrani et al. · 2024 · Nature Communications